2010, Digital Health, Medical Technology and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2010

Digital Health

Medical Technology

Pharmaceuticals

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

OCTOBER 23, 2023

CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. From 2008 until 2010, Mr. Cutler was President and Chief Executive Officer of Sustainable Power Corp.,

Pharmaceuticals

Pharmaceuticals Leadership Life Science Digital Health

Medicine 2.0 : Implications of Connected Medical Devices & Digital Healthcare

Lloyd Price

FEBRUARY 24, 2019

With advances in telemedicine, meanwhile, and with rapid increases in the numbers of next-generation medical devices capable of harnessing artificial intelligence, both doctors and patients now have even more medical information available to them. Compliance considerations Regulatory authorities are eager to promote Medicine 2.0

Life Science

Life Science BioTech Mobile Health Solutions Pharmaceuticals

Connected Health Pulse

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Medicine 2.0 : Implications of Connected Medical Devices & Digital Healthcare

Stay Connected